Purpose: To present our experience in operative treatment of large periocular xanthelasma.

Methods: Sixty-three patients with large periocular xanthelasma were operatively treated in our department. Ipsilateral and/or contralateral lid skin grafts harvested by blepharoplasty, alone or in combination with local flaps, were used. Forty patients (64%) had enough skin to graft the defect after primary xanthelasma removal. In 10 patients, additional local flaps were used: modified rhomboid flap in six patients, local advancement flap in two, and bi-lobed flap in two patients. In three patients (5%), a sequential approach was applied since xanthelasma were too large to be completely removed in a single-step excision. No serious complications were shown.

Results: Patients were followed from 6 months to 8 years. Five patients (8%) returned with recurrences 3-8 years after primary excision.

Conclusions: In lack of the setting for xanthelasma laser treatment, operative approach of a single-step or sequential excision using lid skin graft combined with local flaps proved its value for large periocular xanthelasma.

Download full-text PDF

Source
http://dx.doi.org/10.1080/01676830802418872DOI Listing

Publication Analysis

Top Keywords

large periocular
16
periocular xanthelasma
12
local flaps
12
operative treatment
8
treatment large
8
patients
8
lid skin
8
skin graft
8
flap patients
8
xanthelasma
6

Similar Publications

An Atypical Case of Orbital Wall Infarction Secondary to Sickle Cell Disease in an Adult and Review of Literature.

Ophthalmic Plast Reconstr Surg

December 2024

Moorfields Eye Hospital NHS Foundation Trust, Moorfields Eye Hospital, London, United Kingdom.

Sickle cell disease is known to cause painful vaso-occlusive crises in long bones with large marrows. Orbital infarction is a rare complication of sickle cell disease and usually presents in children and adolescents with acute onset periocular swelling mimicking orbital cellulitis. We describe an atypical case of a 38-year-old man with homozygous sickle cell disease who presented with isolated, complete ptosis of his OD with minimal swelling.

View Article and Find Full Text PDF

Seborrheic dermatitis (SD) often leads to ocular manifestations (OM) that are frequently overlooked. This study comprehensively explains the genesis of these ocular issues, which involves a combination of Malassezia overgrowth, changes in sebum production, and inflammatory responses in the body. The periocular region is rich in sebaceous glands, allowing Malassezia to thrive, which can lead to an inflammatory reaction that spreads to the eye surface, causing disorders such as blepharitis, conjunctivitis, keratitis, and ocular surface diseases.

View Article and Find Full Text PDF

Purpose Of Review: Pseudophakic cystoid macular edema (PCME) is the most common postoperative complication of cataract surgery, resulting in visual decline. In this review, we discuss its pathophysiology, epidemiology, clinical presentation, and the current available evidence on therapeutic management.

Recent Findings: Patients with diabetes mellitus have twice the risk of developing PCME as compared to nondiabetic individuals.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to analyze the link between inflammatory conditions in the eyes and body and the development of pterygium, a growth on the eye's surface.
  • Researchers used electronic medical records from Clalit Health Services in Israel, comparing over 94,000 pterygium patients with nearly 379,000 matched controls based on age, sex, and ethnicity.
  • Results showed significant associations between pterygium and several inflammatory conditions, both ocular (like vernal keratoconjunctivitis and blepharitis) and systemic (like asthma and atopic dermatitis), indicating these conditions may increase the risk of developing pterygium.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!